Archives of Medical Research 31 (2000) S119–S121
0188-4409/00 $–see front matter. Copyright © 2000 IMSS. Published by Elsevier Science Inc.
PII S0188-4409(00)00123-5
Effect of the Prostaglandin Analogue Misoprostol on Resistance to
Entamoeba histolytica Infection in Balb/c Mice
Blanca E. Sánchez-Ramírez,* Ernesto Ramos-Martínez,**
Rocío Gaytán-Ochoa* and Patricia Talamás-Rohana***
*Facultad de Ciencias Químicas,
**Departamento de Anatomía Patológica del Hospital Central Universitario, Facultad de Medicina,
Universidad Autónoma de Chihuahua (UACH), Chihuahua, Mexico
***Departamento de Patología Experimental, Centro de Investigación y de Estudios Avanzados del I.P.N. (Cinvestav), Mexico City, Mexico
Key Words: Entamoeba histolytica, Misoprostol, Prostaglandin, Mice.
Introduction
Amebic liver abscess (ALA) produced by Entamoeba his-
tolytica infection is a common complication of invasive in-
testinal amebiasis. Several experimental models, mainly ro-
dents, have been used to study this parasitic infection,
finding a great variability in susceptibility. Hamsters and
gerbils are susceptible to hepatic amebiasis, while mice
have been difficult to infect either intracecally or intrahepat-
ically (1). Infections have been successfully induced using
congenitally athymic nude (nu/nu) mice pretreated with sil-
ica, which demonstrates that host resistance in murine ame-
biasis is critically dependent upon the macrophage (1). Re-
cent studies have demonstrated that inflammation mediators
such as arachidonic acid (AA) metabolites, particularly
prostaglandin E2 (PGE
2
), can modulate T helper (TH) cells
and participate in regulation of cooperator and effector mac-
rophage functions (2). Previously, we demonstrated that
during development of ALA in hamsters an increase in
PGE
2
plasmatic levels occurs; furthermore, cyclooxygenase
(COX) activity in liver tissue was augmented. In vivo in-
domethacin (INDO) treatment, previous to the infection,
had a beneficial effect on the host by limiting abscess devel-
opment (3). To study the effect of PGs on natural resistance
of Balb/c mice to E. histolytica infection, we tested exoge-
nous PGs administration using the PGs analogue, misopros-
tol (MPL).
Materials and Methods
Treatment and infection procedure. Male in-bred hamsters
(Mesocricetus auratus), weighing approximately 100 g,
were used as susceptible controls. Balb/c mice weighing ap-
proximately 30 g were divided into groups with and without
MPL treatment. Hamsters and mice were infected intrahe-
patically with 7.5 10
5
trophozoites as described previ-
ously (4). MPL (1 10
-4
M) dissolved in sterile water was
injected intraperitoneally (i.p.) daily 1 h prior to the infec-
tion procedure. For the group of infected and MPL-treated
animals, drinking water was added with 0.25 g/mL of
MPL. At days 2, 4, and 7 postinfection, animals were anes-
thetized and killed by exsanguination. Livers and abscesses
were removed to calculate the percentage of liver damage.
Histology and immunohistochemistry. Specimens for his-
tology were obtained from each group and fixed with 10%
phosphate-buffered formalin. After embedding in paraffin,
6–8 m-thick sections were stained with hematoxylin and
eosin (H&E). Liver sections were evaluated for the presence
of trophozoites following the protocol enclosed with the
Histostain-Plus Kit (Zymed Lab., Inc.), using a polyclonal
antiameba antiserum (1:1000 dilution in blocking buffer).
Results
Intrahepatic inoculation of E. histolytica trophozoites in
hamsters induced abscess formation in 100% of the animals.
Lesions had typical macroscopic and microscopic aspects
(4). Livers from infected hamsters at 2, 4, and 7 days postin-
fection showed by immunohistochemistry the presence of
trophozoites mainly at the periphery of necrosis.
Livers from mice infected without MPL treatment
Address reprint requests to: Dra. Blanca E. Sánchez-Ramírez, Facultad
de Ciencias Químicas, UACH, Apdo. Postal 1542-C, 31000 Chihuahua,
Chihuahua, México. Tel.: (+52) (14) 144-492; FAX: (+52) (14) 144-492;
E-mail: bsanche@buzon.uach.mx
Presenting author: Blanca E. Sánchez-Ramírez.